Western Blot (1:5000-1:6000) The optimal working dilution should be determined by the end user.
Restrictions
For Research Use only
Format
Liquid
Buffer
In Tris-glycine, 150 mM NaCl (0.05 % sodium azide)
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
Store at 4°C for short term. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing.
Mann, Backlund, Buchanan, Daikoku, Holla, Rosenberg, Dey, DuBois: "Repression of prostaglandin dehydrogenase by epidermal growth factor and snail increases prostaglandin E2 and promotes cancer progression." in: Cancer research, Vol. 66, Issue 13, pp. 6649-56, (2006) (PubMed).
Backlund, Mann, Holla, Buchanan, Tai, Musiek, Milne, Katkuri, DuBois: "15-Hydroxyprostaglandin dehydrogenase is down-regulated in colorectal cancer." in: The Journal of biological chemistry, Vol. 280, Issue 5, pp. 3217-23, (2005) (PubMed).
Ding, Tong, Liu, Moscow, Tai: "NAD+-linked 15-hydroxyprostaglandin dehydrogenase (15-PGDH) behaves as a tumor suppressor in lung cancer." in: Carcinogenesis, Vol. 26, Issue 1, pp. 65-72, (2004) (PubMed).
Yan, Rerko, Platzer, Dawson, Willis, Tong, Lawrence, Lutterbaugh, Lu, Willson, Luo, Hensold, Tai, Wilson, Markowitz: "15-Hydroxyprostaglandin dehydrogenase, a COX-2 oncogene antagonist, is a TGF-beta-induced suppressor of human gastrointestinal cancers." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, Issue 50, pp. 17468-73, (2004) (PubMed).
Giannoulias, Patel, Holloway, Lye, Tai, Challis: "Differential changes in 15-hydroxyprostaglandin dehydrogenase and prostaglandin H synthase (types I and II) in human pregnant myometrium." in: The Journal of clinical endocrinology and metabolism, Vol. 87, Issue 3, pp. 1345-52, (2002) (PubMed).